Travere Therapeutics, Inc. - Common Stock (TVTX) stock analysis
TVTX · Travere Therapeutics, Inc. - Common Stock
Latest recorded price: USD 49.70
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 32.3%, ROIC -40.3%.
TVTX · Travere Therapeutics, Inc. - Common Stock
Latest recorded price: USD 49.70
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 32.3%, ROIC -40.3%.